Month: May 2023

Guardian Capital Announces May 2023 Distributions for Guardian Capital ETFs

Written by Customer Service on May 16, 2023. Posted in Dividend Reports And Estimates.

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending May 31, 2023, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on May 31, 2023 to unitholders of record on May 25, 2023. The ex-dividend date in each case is May 24, 2023. Guardian Capital ETFs Series of ETF Units DistributionFrequency TSX TradingSymbol Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF Hedged ETF Units Monthly GDEP $0.0746Guardian Directed Equity Path ETF Unhedged ETF Units Monthly GDEP.B $0.0684Guardian Directed Premium Yield ETF Hedged ETF Units Monthly GDPY $0.1231Guardian Directed Premium Yield ETF Unhedged ETF Units Monthly GDPY.B $0.1133GuardPath™ Managed...

Constellation Software’s Perseus Group Completes Acquisition of Winklevoss Technologies

Written by Customer Service on May 16, 2023. Posted in Mergers And Acquisitions.

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) — Constellation Software Inc. (“Constellation”) (TSX: CSU) announced today that it has, through its Perseus Group (“Perseus”), completed the purchase of Winklevoss Technologies, LLC (“WinTech”), a market leading provider of defined benefit pension plan valuation and administration software. Founded in 1987 by Dr. Howard Winklevoss, WinTech is dedicated to being the software standard for defined benefit pension and other post-employment benefit (OPEB) plans. WinTech’s customer base includes some of the world’s top actuarial consultants, investment consulting firms, accounting firms, plan sponsors, plan administrators, and insurance companies. Mark Tillman, General Manager of WinTech commented: “We are excited to be joining the Perseus Group, which marks a significant milestone in WinTech’s...

Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland

Written by Customer Service on May 16, 2023. Posted in Public Companies.

Switzerland is the first European country to approve Glassia®, which received U.S. FDA approval in 2010 Glassia will be commercialized by IDEOGEN AG in Switzerland and the therapy is expected to be available to patients and providers during the second half of 2023 The current Alpha-1 Antitrypsin Deficiency (AATD) market in Switzerland is estimated to be over $15 million annuallyREHOVOT, Israel and HOBOKEN, N.J., May 16, 2023 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Swissmedic has granted marketing authorization for Glassia®[Alpha-1 Proteinase Inhibitor (Human)] in Switzerland for chronic augmentation and...

New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient’s complete health picture

Written by Customer Service on May 16, 2023. Posted in Public Companies.

66 percent of doctors say genetic testing could lead to better outcomes because patients are more proactive about their health after learning about their DNA health profile 34 percent of doctors said they had personally taken a direct-to-consumer genetic health test SUNNYVALE, Calif., May 16, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe) today announced that a new survey, which found that primary care physicians are more and more comfortable discussing genetic testing with their patients than they were two years ago, and that more than two-thirds of those physicians who’ve taken a test themselves would recommend testing for health purposes if a patient inquired. The survey, conducted by Medscape — a leading source of clinical news, health information, and point-of-care tools for healthcare professionals — is...

Digihost Reports Positive Adjusted EBITA for Q1 2023 and Provides Operational Update

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 4, 2022 to its short form base shelf prospectus dated February 23, 2022 HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq: DGHI; TSXV: DGHI), an innovative U.S. based blockchain technology and computer infrastructure company is pleased to provide a summary of the Company’s unaudited financial results for the period ended March 31, 2023 (all amounts in U.S. dollars, unless otherwise indicated), and a 2023 year-to-date update on operations. The Company’s unaudited consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three-month period ended March 31, 2023 have been filed and made accessible under the Company’s...

Verde achieves C$11.1 million revenue, 76% gross margin and C$2.0 million EBITDA in the first quarter of 2023

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q1 2023: C$1.00 = R$3.84) SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company”) is pleased to announce its financial results for the first quarter ended March 31, 2023 (“Q1 2023”). Q1 2023 FinancialsSales of Verde’s multinutrient potassium products, BAKS® and K Forte® sold internationally as Super Greensand® (the “Product”) by volume were 108,000 tonnes, compared to 112,000 tonnes in Q1 2022 and 16,558 tonnes in Q1 2021. Revenue in Q1 2023 was $11.1 million, compared to $11.3 million in Q1 2022 and $0.8 million in Q1 2021. Cash and other receivables held by the Company in Q1 2023 were $34.3 million, compared to $22.3 million in Q1 2022 and $4.8 million in Q1 2021. EBITDA before non-cash...

Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2023

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

SHENZHEN, China, May 16, 2023 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced its unaudited financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial Highlights:Total revenues were US$99.2 million, an increase of 25.5% year-over-year. Cloud computing revenues were US$32.7 million, an increase of 8.2% year-over-year. Subscription revenues were US$29.3 million, an increase of 15.8% year-over-year. Live streaming and other internet value-added services (“Live streaming and other IVAS”) revenues were US$37.2 million, an increase of 58.4% year-over-year. Gross profit was US$39.6 million, an increase of 13.6% year-over-year and gross profit margin...

Jyske Realkredit explores the possibilities of issuing a new euro denominated covered bond

Written by Customer Service on May 16, 2023. Posted in Public Companies.

To Nasdaq Copenhagen A/S 16th of May 2023 Announcement no. 46/2023 Jyske Realkredit explores the possibilities of issuing a new euro denominated covered bond Jyske Realkredit A/S has mandated Commerzbank, Danske Bank, DZ Bank, ING Bank and Jyske Bank to explore the possibilities of issuing a new euro denominated covered bond out of capital centre E. A benchmark transaction is expected to be launched in the near future, subject to market conditions. Questions may be addressed to Anders Lund Hansen, Head of Mortgage ALM, tel. (+45) 89 89 92 20 or Christian Bech-Ravn, Head of Investor Relations, tel. (+45) 89 89 92 25. The information will also be available on Jyske Realkredit’s web site at jyskerealkredit.com. Yours sincerely Jyske Realkredit A/S Please observe that the Danish...

Evaxion to host R&D Day on May 25, 2023

Written by Customer Service on May 16, 2023. Posted in Public Companies.

COPENHAGEN, Denmark, May 16, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the discovery and development of AI-powered immunotherapies, today announced that it will hold an R&D Day at 12:30 p.m CEST on May 25, 2023. The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications. The event will be hosted with the possibility for physical attendance at Evaxion’s facilities in Hørsholm, Denmark and...

Major Shareholder Announcement – AIM international Mutual Funds

Written by Customer Service on May 16, 2023. Posted in Public Companies.

ANNOUNCEMENT NO. 238 16 May 2023 Major shareholder announcementMajor shareholder announcement – AIM International Mutual Funds Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that Invesco Ltd. has informed ChemoMetec A/S that AIM International Mutual Funds (Invesco International Mutual Funds) holds 881,141 shares in ChemoMetec A/S corresponding to 5.06% of the share capital, and that the shareholding thus exceeds the 5 per cent limit in section 38 of the Capital Markets Act.Additional information Niels Høy Nielsen, CFOTelephone (+45) 2551 8724About ChemoMetec A/S ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s...

Month: May 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals